News & Events
Want the latest updates delivered to your inbox?
Subscribe to our newsletter.
Ambassador of Indonesia to Greece visits RGCC facilities in Florina
Florina, Greece
Indonesia’s Ambassador to Greece toured our Florina facilities. He was introduced to our innovative research activities and the high-quality…
RGCC Advocates for Equal Patient Access to Advanced Therapy Medicinal Products (ATMPs) Across the European Union
RGCC aims to promote transparency and collective action toward a fair and unified approach to healthcare access across the…
As part of its CSR activities, RGCC Donates €15,000 to Support CAR-T Cell Therapy Research at Charité – Universitätsmedizin Berlin
RGCC International announces a €15,000 donation to Charité – Universitätsmedizin Berlin to support pioneering CAR-T cell therapy research for…
New Study Demonstrates Benefits of Circulating Tumor Cell Analysis in Ovarian Cancer Care
Powered by RGCC’s Onconomics test, circulating tumor cell (CTC) analysis is transforming ovarian cancer care — helping doctors personalize…
RGCC Supports “Kinder-Hilfe-Mobil” Initiative to Aid Children in Need in Halle (Saale), Germany
RGCC Central Europe has announced its support for CVJM Halle e. V., an organization dedicated to helping children living…
RGCC Signs Letter of Intent to Foster Academic Collaboration with Universitas Hasanuddin and PT Wapindo Jasaartha
RGCC International is proud to announce the signing of a Letter of Intent (LoI) with Universitas Hasanuddin in Indonesia…
RGCC International Announces the Launch of InVyomma Plus: A Revolutionary Gut Microbiome Profiling Test
RGCC International is proud to announce the launch of its latest test, InVyomma Plus. The test is designed to…
RGCC International at DMCCB Basel Symposium 2025: Celebrating Excellence in Cancer Research
RGCC International is honored to have participated in the DMCCB Basel Symposium 2025.
As part of its Corporate Social Responsibility activities, RGCC International Donates CHF 15,000 to Universitäts-Kinderspital Zürich
As part of its ongoing commitment to Corporate Social Responsibility (CSR), RGCC International is proud to announce a donation…
RGCC and PERABOI Sign MOU for a Clinical Study on Circulating Tumor Cells in Breast Cancer
October 4th, 2024 – Bali, Indonesia: RGCC, a leader in advanced diagnostic technologies, and the Indonesian Association of Surgical…
RGCC SA laboratory in Greece receives prestigious certification from Japan’s Ministry Of Health, Labour and Welfare
Japan
RGCC SA is proud to announce that our state-of-the-art laboratory in Greece has been awarded the accreditation certificate of…
New test could spot early signs of prostate cancer
Researchers have used genetic testing to detect the very early changes that occur in the tumours of men with…